| | Identification | Back Directory |  | [Name] 
 LEE011 (succinate)
 |  | [CAS] 
 1374639-75-4
 |  | [Synonyms] 
 LEE011 (succinate)
 Ribociclib succite
 Ribociclib succinate
 Ribociclib Succinate   (Kisqali)
 RIBOCICLIB SUCCINATE (LEE011 SUCCINATE)
 LEE-011 succinate salt, Ribociclib succinate salt
 7-cyclopentyl-N,N-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide succinate
 |  | [Molecular Formula] 
 C27H36N8O5
 |  | [MOL File] 
 1374639-75-4.mol
 |  | [Molecular Weight] 
 552.64
 | 
 | Chemical Properties | Back Directory |  | [Melting point ] 
 >160oC (dec.)
 |  | [storage temp. ] 
 Refrigerator
 |  | [solubility ] 
 DMSO (Slightly), Methanol (Slightly)
 |  | [form ] 
 Solid
 |  | [color ] 
 Pale Beige
 | 
 | Hazard Information | Back Directory |  | [Uses] 
 LEE011 is an orally bioavailable and highly specific CDK4/6 (cyclin-dependent kinase 4/6) inhibitor. LEE011 in combination with LGX818 (a V600E BRAF specific inhibitor) or BYL719 (a PIK3CA specific inhibitor) leads to robust anti-tumor activity in melanoma and breast cancer tumor models.
 | 
 |  |